In the fifth-largest biotech deal in history, Amgen has agreed to buy cancer drug maker Onyx Pharmaceuticals. As part of the deal, Amgen will gain revenue from two of Bayer’s drugs, developed in partnership. The...
ME Interview Series on Globalization, West & Developing Countries with Hervé Azouloy, President of ATHES Finance and Participation & Ezilarsan PKP, founder...